The overexpression of METTL3 in hepatocellular carcinoma (HCC) leads to the degradation of the oncogene SOCS2 through m6A modification, which is associated with poor patient prognosis [17]. This evidence concerns the gene SOCS2 and hepatocellular carcinoma.